KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY

Kahira Pharmaceuticals & Chemical Industries Company

CPCI

EGS38391C016

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 03:30:00 27/05/2024 am IST			5-day change	1st Jan Change
69.19 ^EGP	0.00%		0.00%	+22.35%

2023	Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2023	CI
2023	Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023	CI

Cairo Pharmaceuticals Announces Audited Earnings Results for the Year Ended on June 30, 2017

September 10, 2017

Cairo Pharmaceuticals announced audited earnings results for the year ended on June 30, 2017. For the period, the company's net profit was EGP 97,919,653 as compared to EGP 51,348,424 a year ago.

Latest news about Kahira Pharmaceuticals & Chemical Industries Company

Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2023	12/12	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023	09/23/09	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Nine Months Ended March 31, 2023	23/23/23	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2022	21/22/21	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Third Quarter Ended March 31, 2022	24/22/24	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Third Quarter Ended March 31, 2022	24/22/24	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Half Year Ended December 31, 2021	14/22/14	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2021	14/21/14	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2021	08/21/08	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Nine Months Ended March 31, 2021	11/21/11	CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Six Months Ended December 31, 2020	16/21/16	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Unaudited Earnings Results for the First Half of Fiscal Year 2020	11/20/11	CI
Kahira Pharmaceuticals Reports Earnings Results for the Fiscal Year 2019	29/19/29	CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Nine Months Ended March 31, 2019	15/19/15	CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018	17/19/17	CI
Cairo Pharmaceuticals Announces Reviewed Earnings Results for the Nine Months Ended September 30, 2018	14/18/14	CI
Cairo Pharmaceuticals Declares Cash Dividend Payable on October 28, 2018	10/18/10	CI
Cairo Pharmaceuticals Reports Earnings Audited Results for the Year Ended June 30, 2018	30/18/30	CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2017	12/18/12	CI
Cairo Pharmaceuticals Announces Earnings Results for the First Quarter Ended on September 30, 2017	15/17/15	CI
Cairo Pharmaceuticals Declares Cash Dividends, Payable on October 26, 2017	08/17/08	CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Year Ended on June 30, 2017	10/17/10	CI
Kahira Pharmaceuticals & Chemical Industries Company Announces Earnings Results for the Nine Months Ended March 31, 2017	15/17/15	CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2016	15/17/15	CI
Kahira Pharmaceuticals & Chemical Industries Co Reports Earnings Results for the First Half of Fiscal 2015	29/15/29	CI

Chart Kahira Pharmaceuticals & Chemical Industries Company

Duration

Period

Chart Kahira Pharmaceuticals & Chemical Industries Company

More charts

Cairo Pharmaceuticals specializes in manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, parasitic, dermatological, cardiovascular, allergic diseases, etc. The group also provides veterinary products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY	+22.35%	21.9M
ELI LILLY AND COMPANY	+37.94%	727B
JOHNSON & JOHNSON	-7.89%	354B
MERCK & CO., INC.	+15.48%	328B
ABBVIE INC.	-0.39%	277B
ASTRAZENECA PLC	+13.47%	243B
NOVARTIS AG	+7.35%	205B
ROCHE HOLDING AG	-6.42%	203B
AMGEN INC.	+4.11%	164B
PFIZER, INC.	-1.82%	164B